Skip to main content
Log in

Transkatheter-Aortenklappenimplantation – "TAVI"

  • Published:
Wiener klinische Wochenschrift Education

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  • Grube E, Laborde JC, Gerckens U et al (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation 114:1616-1624

    Article  PubMed  Google Scholar 

  • Behan M, Haworth P, Hutchinson N, et al (2008) Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv 72:1012-1015

    Article  PubMed  Google Scholar 

  • Berry C, Asgar A, Lamarche Y, et al (2007) Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv 70:610-616

    Article  PubMed  Google Scholar 

  • De Jaegere PP, Piazza N, Galema TW, et al (2008) Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve Revalving System aortic valve bioprosthesis. EuroIntervention 4:351-357

    Article  PubMed  Google Scholar 

  • Tamburino C, Capodanno D, Mulè M, et al (2009) Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 21:93-98

    PubMed  Google Scholar 

  • Grube E, Schuler G, Buellesfeld L, et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high risk patients using the second- and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 50:69-76

    Article  PubMed  Google Scholar 

  • Piazza N, Grube E, Gerckens U, et al (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 4:242-249

    Article  Google Scholar 

  • Gerckens U, Latsios G, Mueller R, et al (2010) Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. JACC Cardiovasc Interv 3:244-250

    Article  PubMed  Google Scholar 

  • Ludman PF. The UK TAVI registry. EuroPCR 2010. 25 May 2010–28 May 2010, Paris–France

  • Petronio AS, De Carlo M, Bedogni F, et al (2010) Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 3:359-366

    Article  PubMed  Google Scholar 

  • De Bruyne B, et al. Medium term survival and functional status in patients with severe aortic stenosis treated by transcatheter aortic valvular implantation in the PARTNER EU Trial. The 21st Annual Scientific Sessions Transcatheter Cardiovascular Therapeutics, September 21–25, 2009, San Francisco, California

  • Thomas M. Update from the SOURCE Registry. EuroPCR, 25 May 2010–28 May 2010, Paris–France

  • Thomas M, Schymik G, Walther T, et al (2010) Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry. Circulation 122:62-69

    Article  PubMed  Google Scholar 

  • Rodés-Cabau J, Webb JG, Cheung A, et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. JACC 55;1080-1090

    PubMed  Google Scholar 

  • Leon MB, Smith CR, Mack M, et al for the PARTNER Trial Investigators (2010) Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. Engl J Med 363:1597-1607

    Article  CAS  Google Scholar 

  • Smith CR, Leon MB, Mack MJ, et al for the PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-2198

    Article  PubMed  CAS  Google Scholar 

  • Wisser W, Gabriel H, Mächler H, et al (Task Force der Österreichischen Kardiologischen Gesellschaft und der Österreichischen Gesellschaft für Thorax-Herzchirurgie) (2011) Positionspapier der ÖKG und ÖGTHC zu katheterunterstützten Herzklappeninterventionen. Submitted

  • Vahanian A, Alfieri O, Al-Attar N, et al (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29:1463-1470

    Article  PubMed  Google Scholar 

  • Iung B, Cachier A, Baron G, et al (2005) Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26:2714-2720

    Article  PubMed  Google Scholar 

  • Walther T, Kasimir MT, Doss M, et al (2011) One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 39:532-537

    Article  PubMed  Google Scholar 

  • Lefevre T, Kappetein AP, Wolner E, et al (2011) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148-157

    Article  PubMed  Google Scholar 

  • Thomas M, Schymik G, Walther T, et al (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62-69

    Article  PubMed  Google Scholar 

  • Aupart MR, Mirza A, Meurisse YA, et al (2006) Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1,133 patients. J Heart Valve Dis 15:768-776

    PubMed  Google Scholar 

  • Ruel M, Chan V, Bedard P, et al (2007) Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults < 60 years of age. Circulation 116;I-294-I-300

    Article  Google Scholar 

  • McClure RS, Narayanasamy N, Wiegerinck E, et al (2010) Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: Up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 89:1410-1416

    Article  PubMed  Google Scholar 

  • Kempfert J, Van Linden A, Linke A, et al (2010) Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg 89:1934-1941

    Article  PubMed  Google Scholar 

  • Vahanian A, Otto CM (2010) Risk stratification of patients with aortic stenosis. Eur Heart J 31:416-423

    Article  PubMed  Google Scholar 

  • Spaccarotella C, Mongiardo A, Indolfi C (2011) Pathophysiology of aortic stenosis and approach to treatment with percutaneous valve implantation. Circ J 75:11-19

    Article  PubMed  Google Scholar 

  • Mundigler G, Mascherbauer J, Kasimir MT, Bergler-Klein J. Aortenstenose: Diagnostik, Verlauf und Therapie. Wien Klin Wochenschr 2/2009

  • Faggiano P, Antonini-Canterin F, Baldessin F, et al (2006) Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound 1;4:27

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Neunteufl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scherzer, S., kreiner, G., Stelzmüller, ME. et al. Transkatheter-Aortenklappenimplantation – "TAVI". Wien. Klin. Wochenschr. Educ 6, 130–138 (2011). https://doi.org/10.1007/s11812-011-0014-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11812-011-0014-y

Navigation